PepGen Inc. (PEPG) stock
PEPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.83−0.05 (-1.29%)
Close on Nov 18, 2026Market cap $265.26MP/E –Yield –
PepGen free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
PepGen's free cash flow for the twelve months ending Jun 30, 2026 was -$69.46M. For fiscal 2025 it was -$81.90M. The highest annual figure on record is -$23.10M in fiscal 2021.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$81.90M | – |
| FY2024 | Dec 31, 2024 | -$82.87M | – |
| FY2023 | Dec 31, 2023 | -$71.60M | – |
| FY2022 | Dec 31, 2022 | -$63.02M | – |
| FY2021 | Dec 31, 2021 | -$23.10M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$15.84M | – |
| Q1 FY2026 | Mar 31, 2026 | -$18.43M | – |
| Q4 FY2025 | Dec 31, 2025 | -$15.84M | – |
| Q3 FY2025 | Sep 30, 2025 | -$19.36M | – |
| Q2 FY2025 | Jun 30, 2025 | -$23.64M | – |
| Q1 FY2025 | Mar 31, 2025 | -$23.06M | – |
| Q4 FY2024 | Dec 31, 2024 | -$19.70M | – |
| Q3 FY2024 | Sep 30, 2024 | -$24.20M | – |
| Q2 FY2024 | Jun 30, 2024 | -$16.38M | – |
| Q1 FY2024 | Mar 31, 2024 | -$22.59M | – |
| Q4 FY2023 | Dec 31, 2023 | -$19.61M | – |
| Q3 FY2023 | Sep 30, 2023 | -$16.91M | – |
| Q2 FY2023 | Jun 30, 2023 | -$18.48M | – |
| Q1 FY2023 | Mar 31, 2023 | -$16.60M | – |
| Q4 FY2022 | Dec 31, 2022 | -$14.49M | – |
| Q3 FY2022 | Sep 30, 2022 | -$21.40M | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.25M | – |
| Q1 FY2022 | Mar 31, 2022 | -$13.89M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.14M | – |
| Q3 FY2021 | Sep 30, 2021 | -$7.67M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.15M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.14M | – |
See a number that looks wrong?